
Open Seminar: Available now - COVID-19 monitoring, Dr Jeffrey Barrett
How genome sequencing of COVID-19 virus samples in the UK is helping to guide public health response
Hear how the Sanger Institute has sequenced more than 100,000 SARS-CoV-2 genomes, and how the COVID-19 Genomics UK (COG-UK) Consortium is using the data for surveillance, including the discovery and spread of the B.1.1.7 variant.
Dr Jeffrey Barrett, Director of the COVID-19 Genomics Initiative at the Wellcome Sanger Institute, outlines how the Institute's genome sequencing and analysis expertise is being used to track the rise and spread of new variants of the coronavirus.

COVID-19 research at the Sanger Institute
We are committed to tracking, understanding and combatting COVID-19. Our staff sequence thousands of virus genomes and use the data to trace transmission, inform public health measures and monitor for new variants of the virus. We also work to understand how the virus interacts with our cells, and to develop new diagnostics
Latest News and Blogs
Inside our Institute
Read our stories from the cutting edge of genomic research… and of the people who are making it happen